Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CO2 vs Air Insufflation for Argon Plasma Coagulation in Gastric Bypass Weight Regain
NCT03264027Completed
- Sponsor
- Kaiser Permanente
- Start
- Jan 2017
- Primary completion
- Jan 2020
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Randomised trial of Carbon dioxide in obesity, sponsored by Kaiser Permanente. Primary endpoint: Visual Analogue Scale Pain at 8 weeks. Started Jan 2017; status: completed.
02
Drugs
Carbon dioxide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT03264027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03264027.